Trial · NCT04446598
Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
NCT04446598, Not applicable, Completed, Adrian Gaspar
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser. Trials, record NCT04446598. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04446598
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
- NCT number
- NCT04446598
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 36 participants, actual
- Lead sponsor
- Adrian Gaspar
- Conditions
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Prostatodynia
- Interventions
- non-ablative SMOOTH mode Erbium YAG laser, Tadalafil 5mg
- First posted
- 2020-06-25
- Last updated
- 2020-06-25
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Maximum urethral flow value (Q-max) | Change from Baseline Q-max at 3 and 6 months following the intervention | measurement of maximum urethral flow using uroflowmetry |
| Primary | IPSS questionnaire | Change from Baseline IPSS score at 1, 3, 6 and 12 months following the intervention | Assessment of urinary symptoms using the International Prostate Symptom Score (IPSS) |
| Secondary | pain assesment: VAS (visual analog scale) scale | Change from Baseline pain VAS score at 1, 3, 6 and 12 months following the intervention | subjective assesment of pain using 0 (minimum) to 10 (maximum) VAS scale. 0 means no pain, 10 means worst possible pain; |
| Secondary | dysuria assesment: VAS (visual analog scale) scale | Change from Baseline dysuria VAS score at 1,3, 6 and 12 months following the intervention | subjective assesment of dysuria using 0 (minimum) to 10 (maximum) VAS scale. 0 means no dysuria, 10 means worst possible dysuria; |
| Secondary | Patient satisfaction: 7-point Likert Scale | 6 months following the intervention | subjective assessment of patients' satisfaction with the treatment using 0 to 6 Likert Scale; Question - How satisfied are you with the treatment? Likert scale: 0 - extremely satisfied; 1- very satisfied; 2 - mostly satisfied; 3 - neither satisfied nor unsatisfied; 4 - mostly unsatisfied; 5 - very unsatisfied; 6- extremely unsatisfied |
| Secondary | Patient satisfaction: 7-point Likert Scale | 12 months following the intervention | subjective assessment of patients' satisfaction with the treatment using 0 to 6 Likert Scale; Question - How satisfied are you with the treatment? Likert scale: 0 - extremely satisfied; 1- very satisfied; 2 - mostly satisfied; 3 - neither satisfied nor unsatisfied; 4 - mostly unsatisfied; 5 - very unsatisfied; 6- extremely unsatisfied |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04446598
GET https://conductscience.org/api/trials/v1/NCT04446598/registered